Mathini Ilancheran

ARTICLES BY MATHINI ILANCHERAN

• India’s New Drugs, Medical Devices, And Cosmetics Draft Bill 2022

  11/7/2022

  To accommodate changing requirements and encourage the adoption of new technology, India’s Ministry of Health and Family Welfare released a draft bill in July 2022 to replace the existing Drugs and Cosmetics Act 1940. What are the major areas of change and how much of an impact will there be?

• Decentralized Trials: Trends & Technology Propelling Home Healthcare Services

  6/15/2021

  Moving some trial site activities into patients’ homes has been shown to increase recruitment by 60% or more, and it typically maintains patient retention at over 90%. This article delves into research regarding trends and technology enabling decentralized trials.

• The Asia-Pacific Region: A Hot Spot For Clinical Trials

  3/2/2021

  The Asia-Pacific region has become the hot spot for conducting clinical trials. Why? There is an ease of regulatory compliance, a low cost of conducting studies, a growing patient population, and the presence of a few top clinical institutions acting as sites.

• COVID-19’s Impact On The Clinical Trial Ancillary Supplies Industry

  9/24/2020

  With restrictions on logistics, and countries implementing new restrictions to address increasing COVID-19 cases, it’s important to understand how to manage clinical trials’ ancillary supplies — like sourcing from the right suppliers, managing distribution to all trial sites, stock management, and response to new regulations.

• COVID-19’s Impact On Availability Of Drugs And API From India And China

  4/23/2020

  COVID-19 has caused an increase in demand for APIs and drugs; those used as antimalarials are seeing the highest demand, followed by bronchodilators, antibiotics, and antivirals. This article reviews the drugs and API in demand globally, with assessments of their supply status in India and China.

• COVID-19, Medical Drones, & The Last Mile Of The Pharma Supply Chain

  4/6/2020

  During crises like this pandemic, bottlenecks in drug distribution and sample testing can be improved through automation, artificial intelligence, and robotics. This article provides an overview of the medical drone industry, with a particular emphasis on its adoption by the pharmaceutical sector to solve logistical problems in healthcare during times of heightened need. 

• A Supply Market Review Of Lab Chemicals And Solvents For The Pharmaceutical Industry

  6/19/2019

  The market for high-purity chemical production, distribution, and sales for use in pharma is highly competitive. Most of the products are made to standard specifications and are either produced by or sourced from multiple sources, such as petrochemical companies, chemical manufacturing companies, and chemical distributors. This paper discusses the lab chemicals market and supply chain and key trends that have an impact on pharmaceutical buyers.

• An Introduction To Financial Benchmarking In Biopharma Clinical Development

  10/16/2018

  The high cost and failure rate of new drug candidates going through clinical trials are well documented and a recurring subject of research both by industry and academia.¹ Further, the cost of drug development is a debated topic, and there is no consensus on what the “true cost” is because of the different methods used for these calculations.² The lack of adequate comparable cost data and value measures also makes it difficult for pharmaceutical sponsors and trial sites to implement financial benchmarking for planning, costing, and budget management.

• Measuring The Impact Of Reforms On India’s Clinical Trial Environment

  10/12/2017

  The clinical trial environment in India has seen a downward trend since 2013, when the government approached the Supreme Court regarding the death of 2,644 volunteers during clinical trials over seven years.